首页> 外文期刊>Gastroenterology research and practice >Helicobacter pylori Infection and Upper Gastrointestinal Disorders
【24h】

Helicobacter pylori Infection and Upper Gastrointestinal Disorders

机译:幽门螺杆菌感染和上消化道疾病

获取原文
获取原文并翻译 | 示例
           

摘要

It has been thirty years since the two Australians Robin Warren and Barry Marshall discovered Helicobacter pylori (H. pylori) in 1983 [1]. In order to fulfil the Koch's postulates, Marshall and Morris drank a solution which was a suspension of H. pylori. This produced gastritis from which the bacteria could be reisolated [2]. It will be interesting to see how the approach to treatment has progressed in these three decades after the discovery of the organism-based both on consensus guidelines and other research in this field. The changes in the consensus statements have been highlighted. The isolation of H. pylori from the gastric mucosa and the report of the organism's urease activity generated excitement especially when it was postulated by Marshall that these microorganisms could be the cause of gastritis and could be a dominant etiological factor in the pathogenesis of peptic ulcer disease (PUD). With the isolation of H. pylori, floodgates opened to a new era of discovery and understanding of gastroduodenal pathology.
机译:自从两个澳大利亚人Robin Warren和Barry Marshall于1983年发现幽门螺杆菌(H. pylori)以来已有30年了[1]。为了履行科赫的假设,马歇尔和莫里斯喝了一种溶液,即幽门螺杆菌的悬浮液。由此产生的胃炎可以从中分离出细菌[2]。有趣的是,根据共识指南和该领域的其他研究,在发现生物体后的这三十年中,治疗方法是如何发展的。共识声明中的更改已突出显示。从胃粘膜中分离出幽门螺杆菌,并报告了该生物体的脲酶活性,这引起了兴奋,特别是当马歇尔(Marshall)推测这些微生物可能是胃炎的原因,并且可能是消化性溃疡疾病发病机理的主要病因时(PUD)。随着幽门螺杆菌的隔离,水闸打开了一个新的发现和了解胃十二指肠病理学的时代。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号